









Markets
/
Stocks
/
nasdaq-bbnx
/

Beta Bionics Inc

BBNX

16.420USD

+0.020+0.12%

Close 08/04, 16:00（ET）Quotes delayed by 15 min

703.75MMarket Cap

LossP/E TTM



Beta Bionics Inc

16.420

+0.020+0.12%

Overview Company Financials

Income Statement

Cash Flow Statement

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024Q4

FY2024Q3

Total equity

Cash, cash equivalents and short-term investments

--103.58M

--60.90M

- Cash and cash equivalents

--30.43M

--17.48M

-Short-term investments

--73.14M

--43.42M

Receivables

--12.00M

--7.46M

-Accounts and notes receivable

--12.00M

--7.46M

Inventory

--13.32M

--11.29M

Prepaid expenses

--2.98M

--2.60M

Other current assets

--1.05M

--305.00K

Total current assets

--132.92M

--82.56M

Non-current assets

Net Fixed Assets

--11.42M

--11.04M

-Fixed Assets

--16.67M

--16.06M

-Accumulated depreciation

--5.25M

--5.02M

Other non-current assets

--5.30M

--3.35M

Total non-current assets

--16.72M

--14.38M

Total assets

--149.65M

--96.94M

Liabilities

Current liabilities

-Other payables

--994.00K

--785.00K

Accrued expenses

--14.83M

--12.25M

Deferred liabilities

--939.00K

--550.00K

Other current liabilities

--1.93M

--1.33M

Total current liabilities

--21.15M

--17.88M

Non-current liabilities

Long-term debt and lease liabilities

--5.73M

--5.85M

-Long-term lease liabilities

--5.73M

--5.85M

Deferred liabilities

--1.86M

--1.47M

Other non-current liabilities

--46.76M

--40.34M

Total non-current liabilities

--52.48M

--46.19M

Total liabilities

--73.63M

--64.07M

Shareholders' equity

Common equity

--51.31M

--49.72M

Retained earnings

---296.74M

---278.63M

Capital reserves

--51.31M

--49.72M

Gains losses not affecting retained earnings

--65.00K

--58.00K

Total equity

--76.01M

--32.87M

Currency unit

USD

USD

Audit opinions

--

--

KeyAI

